Hofseth BioCare ASA (HBC.OL) Stock Analysis & Winston Score
Hofseth BioCare is a Norwegian company that turns leftover salmon parts — bones, skin, and organs — into health ingredients. Its main products include salmon oil rich in omega-3 fatty acids, protein hydrolysates, and calcium powders, which it sells to food, supplement, and pharmaceutical companies. The company is part of Norway's large salmon farming industry and positions itself as a sustainable ingredient supplier by using fish waste that would otherwise be discarded. The company earns revenue by selling these ingredients in bulk to business customers, rather than selling directly to consumers. It operates primarily in Norway but sells to international markets, including Europe and Asia. Its competitive edge comes from its patented low-temperature processing technology, which it claims preserves the quality of the ingredients better than standard methods. The key growth driver is rising global demand for omega-3 and marine protein products, but with an operating margin of around -44%, the company must significantly grow sales volume to reach profitability.
Winston Score: 14/100 — Weak
Weak fundamentals across most pillars.
- Quality: Weak (1/30)
- Growth: Weak (2/20)
- Cash Flow: Weak (0/10)
- Stability: Data not available (0/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
Key Facts
Price: 1.34 NOK
Market Cap: 553M NOK
Sector: Consumer Defensive
Industry: Packaged Foods
Exchange: Oslo Stock Exchange
